Uncommon Therapeutics

San Francisco, United States

Uncommon Therapeutics focuses on building drugs for rare diseases using cutting-edge technology.

$500K raised

Mar 2025

Pre-Seed

Biotechnology Genetics Therapeutics

Top Investors

Y CombinatorPioneer Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Uncommon Therapeutics

How much funding has Uncommon Therapeutics raised?

Uncommon Therapeutics has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2025.

Who are Uncommon Therapeutics's investors?

Uncommon Therapeutics's investors include Y Combinator, Pioneer Fund.

Where is Uncommon Therapeutics headquartered?

Uncommon Therapeutics is headquartered in San Francisco, United States.

What does Uncommon Therapeutics do?

Uncommon Therapeutics focuses on building drugs for rare diseases using cutting-edge technology.

What stage is Uncommon Therapeutics at?

Uncommon Therapeutics is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 1, 2025.

MLA

"Uncommon Therapeutics — Funding & Investors." VCBacked, March 1, 2025, https://www.vcbacked.co/company/uncommon-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2025). Uncommon Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/uncommon-therapeutics

Wikipedia (cite web)

{{cite web |title=Uncommon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/uncommon-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 1, 2025.

Similar Companies in Biotechnology